Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Sleep Apnea, Obstructive 2Polycystic Ovary Syndrome 2Sleep Apnea Syndromes 1Obesity 1Metabolic Syndrome 1Insulin Resistance 1Glucose Intolerance 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Continuous Positive Airway Pressure × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

NCT00805207 2018-08-01

SCOR

Washington University School of Medicine

Phase NA Completed
61 enrolled 17 charts
Other

Obesity, Polycystic Ovary Syndrome, Sleep Apnea Syndromes, Sleep Apnea, Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡